BC Week In Review | Jul 13, 2015
Clinical News

AntriaBio preclinical data

AntriaBio said a single subcutaneous dose of 37.5 mg/kg AB101 in rats and a single subcutaneous dose of 10 or 37.5 mg/kg AB101 in dogs led to a maximum insulin concentration (Cmax) of >30 ng/mL...
BC Week In Review | Jan 14, 2013
Company News

AntriaBio, PR Pharma deal

AntriaBio will reverse-merge with public shell company Fits My Style Inc. (OTCQB:FMYYD, Menlo Park, Calif.) in a stock deal. AntriaBio shareholders exchanged all of their shares for an undisclosed number of outstanding shares of Fits...
Items per page:
1 - 2 of 2